31 studies found for:    Proellex
Show Display Options
Rank Status Study
1 Completed Proellex Pharmacokinetics Bridging Study
Condition: Healthy
Intervention: Drug: Proellex
2 Completed A Study of the Selective Progesterone Receptor Modulator Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
Condition: Uterine Leiomyomata
Interventions: Drug: Progenta;   Drug: Lucron Depot;   Drug: Placebo
3 Completed
Has Results
Two Year Extension Study of the Selective Progesterone Receptor Modulator Proellex® (CDB-4124) in Pre-Menopausal Women With Symptomatic Leiomyomata Who Have Previously Completed Study ZPU 003
Condition: Uterine Fibroids
Interventions: Drug: Proellex®;   Drug: Placebo
4 Completed Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: Proellex 12.5 mg;   Drug: Proellex 25 mg;   Drug: Placebo
5 Completed Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200
Condition: Uterine Fibroids
Interventions: Drug: Proellex 12 mg;   Drug: Proellex 24 mg
6 Terminated Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: Proellex®;   Drug: Placebo
7 Completed Proellex® Pharmacokinetic Bridging Study II
Condition: Healthy
Intervention: Drug: Proellex 25 mg
8 Terminated Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: Proellex® 25 mg;   Drug: Proellex® 50 mg
9 Completed Evaluate the Safety and PK of Proellex® in Female Patients With Impaired Hepatic Function and Healthy Adults
Conditions: Impaired Liver Function;   Healthy Volunteers
Intervention: Drug: Proellex
10 Terminated A Study Evaluating the Safety of 25 and 50 mg Proellex® (CDB-4124) in the Treatment of Premenopausal Women With Symptomatic Uterine Fibroids
Condition: Uterine Fibroids
Intervention: Drug: Proellex
11 Completed Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids
Condition: Uterine Fibroids
Intervention: Drug: telapristone acetate
12 Completed A Safety and Pharmacokinetic Study of Proellex®
Condition: Healthy
Intervention: Drug: Proellex
13 Terminated Study to Evaluate Menses Induction in Women Administered Proellex
Condition: Amenorrhea
Interventions: Drug: Placebo;   Drug: Proellex
14 Terminated Study Evaluating the Safety and Efficacy of the Selective Progesterone Receptor Modulator Proellex® in the Treatment of Premenopausal Women With Symptomatic Endometriosis-extension Study
Condition: Endometriosis
Intervention: Drug: Proellex®
15 Completed Comparison of Two Formulations of Proellex for Vaginal Administration
Condition: Comparison of 2 Different Formulations of 12 mg Proellex Vaginal Capsules
Interventions: Drug: Proellex Formulation A;   Drug: Proellex Formulation B
16 Completed Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects
Condition: Drug Interactions
Intervention: Drug: Proellex®
17 Terminated Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: Proellex 25 mg;   Drug: Proellex 50 mg;   Drug: Lupron Depot
18 Terminated Three Cycle Extension Study Evaluating Safety and Efficacy of a 25 mg Daily Dose of Proellex® In Pre-Menopausal Women With Leiomyomata Who Have Previously Completed ZPU 003 Ext
Condition: Uterine Fibroids
Intervention: Drug: Proellex®
19 Terminated Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids
Conditions: Uterine Fibroids;   Anemia
Interventions: Drug: Proellex 25 mg;   Drug: Proellex 50 mg;   Drug: Placebo
20 Terminated Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids
Conditions: Uterine Fibroids;   Anemia
Interventions: Drug: Proellex 25 mg;   Drug: Proellex 50 mg;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results
Indicates status has not been verified in more than two years